SCHEMBL7962367

SCHEMBL7962367

CCOC(=O)c1[nH]c(COC(C)=O)c(C(C)=O)c1C

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.55
XBP1 P17861 1/20 0.53
ALDH1A1 P00352 6/20 0.53
MAPK1 P28482 3/20 0.53
CYP1A2 P05177 3/20 0.50
POLB P06746 2/20 0.50
CYP2C9 P11712 2/20 0.50
CYP2C19 P33261 2/20 0.50
KMT2A Q03164 2/20 0.50
TSHR P16473 3/20 0.49
KDM4E B2RXH2 2/20 0.49
CASP1 P29466 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
L3MBTL1 Q9Y468 3/20 0.49
LMNA P02545 1/20 0.49
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
HTT P42858 1/20 0.47
RAB9A P51151 3/20 0.47
NPC1 O15118 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12050225 0.88 NPC1 (0.56) HPGDXBP1ALDH1A1MAPK1CYP1A2
SCHEMBL8909803 0.87 CYP1A2 (0.52) HPGDXBP1ALDH1A1MAPK1CYP1A2
SCHEMBL8911652 0.85 CYP1A2 (0.44) HPGDXBP1ALDH1A1MAPK1CYP1A2
SCHEMBL8796711 0.84 LMNA (0.49) XBP1ALDH1A1MAPK1CYP1A2POLB
SCHEMBL7963533 0.83 RAB9A (0.73) HPGDALDH1A1MAPK1POLBKMT2A
SCHEMBL1450411 0.79 HPGD (0.80) HPGDXBP1ALDH1A1MAPK1CYP1A2
SCHEMBL27428734 0.76 HPGD (0.60) HPGDXBP1ALDH1A1MAPK1CYP1A2
SCHEMBL4464908 0.74 ALDH1A1 (0.82) HPGDXBP1ALDH1A1MAPK1CYP1A2
SCHEMBL13983356 0.73 LMNA (0.54) HPGDXBP1ALDH1A1MAPK1CYP1A2
SCHEMBL11648815 0.73 HPGD (0.65) HPGDXBP1ALDH1A1MAPK1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6201129-B1 ANTICARCINOGENIC AGENTS UNIV. COLLEGE CARDIFF CONSULTANTS (GB) 2001-03-13 US disclosed
US-5770598-A ANTITUMOR AGENTS; REACTING WITH CARBONYL DIIMIDAZOLE AND AMIDOXIMES UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (GB) 1998-06-23 US disclosed
EP-0807113-A1 TRICYCLIC DERIVATIVES AND THEIR USE AS ANTI-CANCER AGENTS University College Cardiff Consultants Limited (GB) 1997-11-19 EP disclosed
US-5679694-A LOW TOXICITY AGAINST NORMAL CELL LINES THE WELLCOME FOUNDATION LTD. (GB) 1997-10-21 US disclosed
WO-1995021171-A1 TRICYCLIC DERIVATIVES AND THEIR USE AS ANTI-CANCER AGENTS UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (GB) 1995-08-10 WO disclosed
EP-0651750-A1 TETRACYCLIC COMPOUNDS PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOUR AGENTS THE WELLCOME FOUNDATION LIMITED (GB) 1995-05-10 EP disclosed
WO-1994002483-A1 TETRACYCLIC COMPOUNDS PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOUR AGENTS THE WELLCOME FOUNDATION LIMITED (GB) 1994-02-03 WO disclosed